Oculus Innovative Sciences has obtained 510(k) approval from the US Food and Drug Administration (FDA) for its new Microcyn scar management HydroGel, intended to manage old and new hypertrophic and keloid scarring resulting from burns, ...
At the 9th annual ICIS Base Oils and Lubricants conference, Dec. 4-6, 2013, in New Jersey, Elevance Renewable Sciences, Inc. announced recent developments in renewable synthetic lubricant basestocks designed to provide differentiated ...
Tags: Synthetic Lubricant, Construction
Teva Pharmaceutical has licensed rights to commercialize glatiramer acetate to Takeda Pharmaceutical in Japan as part of their agreement signed earlier in 2013. Currently both the firms are working on additional agreements for ...
Tags: Teva Licenses, Medicine
Alliance Grain Traders (AGT), a Canadian pulse, staple food and ingredient processor, has outlined plans to expand its Minot, North Dakota pulses ingredient production site with the installation of a second production line. The $4m ...
OncoMed Pharmaceuticals and Celgene have entered into an agreement to jointly develop and commercialize about six anti-cancer stem cell (CSC) product candidates from OncoMed's biologics pipeline, including demcizumab (OMP-21M18, Anti-DLL4). ...
Tags: clinical studies, Medicine, OncoMed
Rehrig Pacific Company, a leading manufacturer of reusable transport packaging systems for grocery, retail, pharmaceutical, food and beverage, agriculture, and recycling and waste industries has released a study in partnership with Clemson ...
Tags: Manufacturing, Processing Machinery, Packaging Machinery
Taiwan-based JHL Biotech and Switzerland-based Selexis have formed a biologic drug development alliance to serve the biopharmaceutical industry. JHL Biotech and Selexis have signed a non-exclusive strategic agreement to provide seamless ...
Tags: Health, Medicine, taiwan, Biologic Drug
CDRD Ventures, the commercialization vehicle of The Centre for Drug Research and Development (CDRD), has announced the launch of a new spin-off company, Sitka Biopharma is a biotechnology company developing a new bladder cancer treatment. ...
Pirelli & C. S.p.A. and its Russian business partners are broadening their cooperation to include joint research and development activities, according to the terms of a memorandum of understanding signed on Wednesday in Moscow. The ...
Tags: Pirelli, R&D, Broaden Jv
The US Food and Drug Administration (FDA) has granted orphan drug designation to Conatus Pharmaceuticals' drug candidate emricasan for the treatment of liver transplant patients with reestablished fibrosis to delay the progression to ...
TUALATIN, Ore., Dec. 2, 2013 /PRNewswire/ -- CUI Global, Inc. (NASDAQ: CUI), a platform company dedicated to the acquisition, development, and commercialization of new, innovative products and technologies, today announced that its wholly ...
Tags: liquid natural gas, energy
Cobalt International Energy, Inc. ("Cobalt") (NYSE:CIE) confirmed today that it has successfully tested its previously announced Lontra #1 Pre-salt discovery well in Block 20, offshore Angola. During the recently completed drill stem test, ...
Tags: Metallurgy, Mineral, Energy
US-based pharmaceutical firm Egalet has entered into a definitive collaboration and license agreement with Japan-based Shionogi for the development and commercialization of multiple oral abuse-deterrent hydrocodone opioid product candidates ...
Tags: Egalet, Product Candidates
Dialog Semiconductor plc (FWB: DLG), a provider of highly integrated power management, AC/DC, solid state lighting and short-range wireless technologies, today announced a strategic collaboration with Sengled, a global leading provider of ...
Tags: Dialog Semiconductor, Lighting
PPG Industries and Universal Display Corporation today marked the opening of a world-class organic light-emitting diode (OLED) materials production facility at PPG's Barberton, Ohio plant. This new site, which PPG owns and operates, ...